ARCHIVES

Clinical Biomarker Discovery Initiative would speed progress in early detection and measurement of response to therapy, Leland Hartwell tells NCI.

This article is from The Cancer Letter archive.

Vol. 30 No. 43 | November 12, 2004

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends TICE BCG Approval For Recurrent Bladder Cancer Prevention

January 10, 1997

New Publication Describes End-of-Life Care Projects

August 29, 2003

Electric Blankets May Be Risk Factor In Childhood Cancer

May 18, 1990

Science Policy: Second-Hand Smoke Linked To Lung Cancer, Other Health Effects

November 26, 1999

Trials Approved by NCI CTEP For The Month of February

February 24, 2012

Legal experts say too many conflicts involved. HHS gave von Eschenbach a waiver for his role in C-Change.

September 30, 2005